Viatris’ Mylan and Hetero Drugs are to supply dolutegravir-based treatment regimens for HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia after agreeing to partner with the Medicines Patent Pool.
Last November, the MPP and ViiV Healthcare signed a new voluntary licensing agreement to enable greater access for dolutegravir-based regimens...





